Tolcapone
1 NDC across 1 manufacturer|0 Generic,1 Brand
Tolcapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 29, 1998, and the first generic was approved Mar 26, 2015. In 2024, Medicare Part D spent $484K on Tolcapone across 138 claims for 20 beneficiaries.
Tolcapone is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $105.98 to $105.98 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$105.98 – $105.98
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch Health US LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Catechol-O-Methyltransferase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing TOLCAPONE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TASMAR 100 MG TABLET | $105.9846 per EA | — |
Frequently Asked Questions
What is Tolcapone used to treat?
Tolcapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Tolcapone become available as a generic?
FDA approved the first generic Tolcapone (ANDA) on Mar 26, 2015.
How much does Medicare spend on Tolcapone?
In 2024, Medicare Part D spent $484K on Tolcapone across 138 claims for 20 beneficiaries.
How many Tolcapone products are on the market?
The Tolcapone drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Tolcapone?
NADAC reference prices for Tolcapone range from $105.9846 to $105.9846 per EA.
Which manufacturers make Tolcapone?
1 manufacturer lists Tolcapone in NADAC. Ranked by number of NDCs, the largest are Bausch Health US LLC (1).